On February 18, the Hengyang Digestive Endoscopy Professional Committee held the 2023 Inflammatory Bowel Disease Specialist Training Coursethe awarding ceremony for the Inflammatory Bowel Disease Quality of Care Center (IBDQCC).

On February 18, the Hengyang Digestive Endoscopy Professional Committee held the 2023 Inflammatory Bowel Disease Specialist Training Coursethe awarding ceremony for the Inflammatory Bowel Disease Quality of Care Center (IBDQCC). Through the persistent efforts of Professor Liao Aijuns IBD-MDT team, the First Affiliated Hospital of University of South China has been awarded the title of "IBDQCC".

The conference featured distinguished speakers including Professor Wu Xiaoping (Chief Inflammatory Bowel Disease (IBD) Expert from the Department of Gastroenterology, Xiangya Second Hospital), Professor Zhou Hongbing (Zhuzhou Central Hospital), Professor Liao Aijun (the First Affiliated Hospital of University of South China), Professor Wu Qing (Affiliated Nanhua Hospital of University of South China), Professor Zhou Hongyu (the 922nd Hospital of the Joint Logistics Support Force, PLA),Professor Feng Yingjuan (the Second Affiliated Hospital of University of South China), with Professor Zeng Bin from the Department of Gastroenterology of the First Affiliated Hospital of University of South China chairing the event. At the meeting, Professor Wu Xiaoping delivered an academic report on "InitiationAbandonment of Diagnostic Anti-Tuberculosis Treatment for Intestinal Ulcers", Professor Liao Aijun shared his experience on "How to Build IBD-MDTStandardized Management",Professor Zhou Hongbing gave a speech on "ScreeningEfficacy Monitoring Before the Application of Biological Agents", followed by lively expert discussions.

The Inflammatory Bowel Disease Quality of Care Center (IBDQCC), jointly established in 2018 by the Chinese Society of Gastroenterology of Chinese Medical AssociationChina Health Promotion Foundation, serves as an official institution dedicated to promoting standardized IBD managementIBD medical center development in China. Currently, the diagnosistreatment of IBD still face significant difficultieschallenges. Despite significant advances in Chinas IBD field over the past decade, its development still represents a late start nationwide. While numerous healthcare institutions have established IBD centers, most teams remain in the early stages of understanding the disease. There is a lack of understanding on how to establish standardized centers that meet clinical diagnosistreatment needs, implement standardized process management,define treatment goals, which affects the diagnosistreatment outcomes of IBD patients. Therefore, it is imperative to establish IBD diagnosistreatment centers to enhance the quality of diagnosistreatmentimprove prognoses. The establishment of IBDQCC has played a pivotal role in advancing standardized IBD diagnosistreatmentimproving patients quality of life across Chinese medical institutions.